Bioprosthetics Market Size Worth US$ 11.13 billion by 2030 | Exclusive Report by Growth Plus Reports

Advertisement

Pune, Dec. 14, 2022 (GLOBE NEWSWIRE) — As per the report published by Growth Plus Reports the Global Bioprosthetics Market was estimated at US$ 4.41 billion in 2021 and is expected to surpass a valuation of US$ 11.13 billion by 2030, progressing at a CAGR of 10.84% from 2022 to 2030. The report provides a detailed analysis of top winning strategies, drivers & opportunities, competitive scenarios, wavering market trends, market size, statistics & estimations, and major investment pockets. Recommendations of bioprosthetics in cardiovascular disorders are increasing market potential.

Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/bioprosthetics-market/8020

The global bioprosthetics market has been analyzed from three perspectives: by type, by application, and by region.

Advertisement

Rising prevalence of cardiovascular disorders such as aortic valve stenosis, and mitral insufficiency is the major factor propelling the market growth. Recommendation of bioprosthetics by physicians has significantly increased in most instances. Moreover, the key benefit of biological valves is that there is less chance for clots formation, reducing the need for ongoing anticoagulant therapy.

Excerpts from ‘by Type’

The global bioprosthetics market according to type is bifurcated into:

  • Allografts
  • Porcine
  • Bovine
  • Xenografts

Among these the xenografts dominated the market in 2021. Whereas porcine segment is expected to show lucrative growth in the coming years. Bioprosthetic xenografts are mostly in great demand for treating cardiovascular diseases. Scientists and cardiac surgeons started to suggest using xenografts as a possible alternative to human heart valves. The use of xenograft tissue to create a heart valve has several advantages, and it is possible to create an endless supply of valves of various sizes. Porcine valve tissues are both crosslinked in low glutaraldehyde concentrations to reduce their antigenicity and to stabilize tissue against proteolytic degradation that would otherwise take place after implantation into the recipient. Allografts prosthesis is characterized by higher implant survival and functional performance, which has improved the long-term outcome.

Excerpts from by Application’

The cardiovascular and plastic surgery segments make up the majority of the global bioprosthetics market. The primary driver of the segment’s growth is a significant increase in the number of patients. Additionally, because they do not need lifelong warfarin therapy. Glutaraldehyde is used to cross-link bioprosthetic valves in order to reduce immunogenicity and ensure chemical stability. The category for plastic surgery and wound healing is anticipated to grow at a rapid CAGR throughout the forecast period. This is related to the rise in demand for minimally invasive procedures.

Excerpts from ‘By Region’

Regionally, the global bioprosthetics market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

North America dominated the market in 2021. The region is majorly influenced by the increasing prevalence of heart diseases. Moreover, demand for minimally invasive techniques is increasing the demand of bioprosthetics in North America. Europe is the second leading region in global bioprosthetics market. Presence of many market players in the region, and their new strategies such as introduction of novel products is positively impacting the market. For instance, Perceval S suturless valve by Sorin corporation is widely available in Europe. Asia pacific is expected to show high growth in coming years.

Get your Customized Research Report: https://growthplusreports.com/inquiry/customization/bioprosthetics-market/8020

Excerpts from ‘Competitive Landscape’

Some of the prominent players operating in the bioprosthetics market are:

  • LeMaitre Vascular, Inc.
  • Labcor Laboratories Ltd.
  • Medtronic plc.
  • Getinge Group
  • CryoLife, Inc
  • Sorin Group
  • Ethicon, Inc.
  • Organogenesis, Inc.
  • LifeCell International
  • St. Jude Medical, Inc.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trend (COVID-19 Perspective)
    2. Technological Trends
    3. Key Players & Competitive Positioning (2021)
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL BIOPROSTHETICS MARKET – ANALYSIS & FORECAST, BY TYPE
    1. Allografts 
    2. Porcine 
    3. Bovine 
    4. Xenografts
  6. GLOBAL BIOPROSTHETICS MARKET – ANALYSIS & FORECAST, BY APPLICATION
    1. Plastic surgery & Wound Healing 
    2. Cardiovascular

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Directly Purchase Premium Copy of Bioprosthetic Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=D7VINQlgFDgQoKGHng86EjqJF3p5QZUDh5Bgv9VJ&report_id=8020&license=Single&submit=

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] Phone no: +91 96545 76783 Web: https://growthplusreports.com/  Follow Us: LinkedIn | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.